CVR

  • World

    Icosavax deal CVR based on FDA approval for IVX-A12, sales in EU, UK, Canada

    Lisa Maree Williams/Getty Images News The $5 a share contingent value right in Astrazeneca’s (NASDAQ:AZN) planned $1.1 billion purchase of…

    Read More »
Back to top button